The company says it will step up the rollout of its reduced-nicotine content cigarettes.Read More
Tags :22nd Century Group
The appointee is currently CFO of GVB Biopharma, which 22nd Century acquired in May.Read More
A pioneer in nicotine reduction, 22nd Century is well-placed as FDA mulls a mandate for minimally addictive cigarettes. Read More
The ex-Swisher CEO will help 22nd achieve the potential of its reduced-nicotine business. Read More
A presentation regarding the integration can be found on the company's website.Read More
The hemp-derived active ingredients provider is expected to more than double 22nd Century’s revenue.Read More
The group believes that FDA's plan to reduce nicotine and ban menthol will work in its favor. Read More
The sales are part of a national pilot for VLN, the first cigarette to receive modified-risk orders.Read More
Treat brings experience from some of the world’s largest plant science companies. Read More
The firm is evolving from pure science to selling branded cigarettes and licensing IP. Read More